Registry for patients undergoing colorectal surgery for cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry invites adult patients undergoing colorectal surgery for colorectal cancer to participate in the collection of epidemiological data. It includes the establishment of tumor tissue and blood banks to analyze genetic mutations and disease-specific biomarkers, particularly focusing on conditions like Lynch syndrome and other hereditary cancers. The registry aims to facilitate basic and clinical research projects on colorectal cancer at the Hospital Italiano de Buenos Aires, promoting collaboration with other institutions. Specific goals include efficient patient enrollment, development of biological sample logistics, and creation of a dynamic data recording system.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients undergoing colorectal surgery for colorectal cancer.

Exclusion Criteria:

* Unwillingness to participate.

Where it's running

• Hospital Italiano de Buenos Aires
  Caba, Buenos Aires, Argentina Recruiting

Study contacts

• Principal investigator: Carlos Vaccaro, MD — Hospital Italiano de Buenos Aires
• Study coordinator: Carlos Vaccaro, MD
• Email: carlos.vaccaro@hospitalitaliano.org.ar

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• PRIORITY-CONNECT 2: virtual prehabilitation and recovery support for people having colorectal cancer surgery

  This trial tests whether a personalised virtual prehabilitation and recovery program with exercise, nutrition, and mental health support can lower 30-day complications for people having colorectal cancer surgery compared with usual care.

  Recruiting at 13 sites Surgical Outcomes Research Centre (SOuRCe) · Coffs Harbour, New South Wales and 30 other locations · NCT06976710

• Nocardia rubra cell wall skeleton added to prior second- or third-line therapy for potentially hazardous stable colorectal cancer

  This test tries adding Nocardia rubra cell wall skeleton to prior second- or third-line treatments for adults with advanced colorectal cancer who have a potentially hazardous stable disease to see if it better controls their cancer.

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06356714

• Blood test for early detection of colorectal cancer and adenomas

  This study is testing a new blood test to see if it can help find early signs of colorectal cancer and adenomas in people who are already scheduled for a colonoscopy.

  Recruiting at 6 sites City of Hope Medical Center · Monrovia, California and 5 other locations · NCT06342440

• Detecting early onset colorectal cancer using a blood test

  This study is testing a new blood test that looks for specific markers to help find early signs of colorectal cancer in young adults.

  Recruiting at 13 sites City of Hope Medical Center · Duarte, California and 12 other locations · NCT06342401

• Assessing minimal residual disease in colorectal cancer using blood tests

  This study is testing if a blood test for cancer DNA can help doctors find out which colorectal cancer patients are at risk of their cancer coming back after surgery and if they need extra treatment.

  Recruiting at 9 sites University of Aarhus · Copenhagen, Capital Region of Denmark and 9 other locations · NCT06076811

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.